Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tririga MG 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Kaipro Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Tririga MG 2mg/500mg/0.2mg Tablet

Diabexe Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Diabexe Trio should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is one component of a comprehensive diabetes management plan that includes a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are paramount in diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Consistent meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling (edema), blurred vision, bone fractures, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring, along with blood cell count and liver function tests as directed by your doctor, are necessary.

Primary Ingredients of Tririga MG 2mg/500mg/0.2mg Tablet

No text was provided to rewrite.

Uses of Tririga MG 2mg/500mg/0.2mg Tablet

Managing Type 2 Diabetes

Major Benefits of Tririga MG 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Tririga MG 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

Common Side effects of Tririga MG 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Tririga MG 2mg/500mg/0.2mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tririga MG 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Tririga MG 2mg/500mg/0.2mg Tablet works:

Each Tririga MG tablet (2mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Tririga MG 2mg/500mg/0.2mg Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tririga MG 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Tririga MG 2mg/500mg/0.2mg Tablet while breastfeeding is likely unsafe. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar fluctuations.

KidneyKidneyUNSAFE

The use of Tririga MG 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, its administration is discouraged in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Tririga MG 2mg/500mg/0.2mg tablets. Dosage modification may be necessary. Medical advice is recommended. A reduced initial dose is typically prescribed for patients with mild to moderate liver disease; the medication is unsuitable for those with severe hepatic dysfunction.

What if you forget to take Tririga MG 2mg/500mg/0.2mg Tablet :

Should you forget to take your Tririga MG 2mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tririga MG 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Tririga MG 2mg/500mg/0.2mg Tablet

Tririga MG Tablet (Glimepiride/Metformin/Voglibose 2mg/500mg/0.2mg) treats type 2 diabetes mellitus in adults. This combination medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Tririga MG 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infections.
Tririga MG 2mg/500mg/0.2mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Tririga MG 2mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Tririga MG 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Tririga MG 2mg/500mg/0.2m...
107
MRP 130
17% off